Concepedia

Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes

Keiko K. Fujisawa, Naoto Katakami, Hideaki Kaneto, Toyoko Naka, Mitsuyoshi Takahara, Fumie Sakamoto, Yoko Irie, Kazuyuki Miyashita, Fumiyo Kubo, Tetsuyuki Yasuda,

Atherosclerosis · 2013 · 100 citations · 13 references

DOI

Concepts

References

13

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

Lisa Park, Kathleen G. Raman, Kenneth J. Lee et al. · Nature Medicine · 1998 · 1.1K citations

, , +16

RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice

Loredana Bucciarelli, Thoralf Wendt, Wu Qu et al. · Circulation · 2002 · 563 citations · Full text

, , +13

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane‐bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

Angela Raucci, Simona Cugusi, Antonella Antonelli et al. · The FASEB Journal · 2008 · 542 citations

, , +13

Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men

Colomba Falcone, Enzo Emanuele, Angela D’Angelo et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 378 citations · Full text

, , +14

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins.

Ann Marie Schmidt, M. Hasu, Doina Popov et al. · Proceedings of the National Academy of Sciences · 1994 · 322 citations

, , +13